LPS nephropathy in mice is ameliorated by IL-2 independently of regulatory T cells activity

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Bertelli, Roberta ^a   Di Donato, Armando ^a   Cioni, Michela ^a   Grassi, Fabio ^b,c   Ikehata, Masami ^c   Bonanni, Alice ^a   Pia Rastaldi, Maria ^d   Ghiggeri, Gian Marco ^a  

^a G GASLINI INSTITUTE   (Italy)

^b INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^c UNIVERSITY OF MILAN   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; PURINERGIC P2X7 RECEPTOR; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FOCAL GLOMERULOSCLEROSIS; KIDNEY DISEASE; KIDNEY HYPERTROPHY; LYMPH NODE; MALE; MOUSE; NONHUMAN; PROTEINURIA; REGULATORY T LYMPHOCYTE; SPLEEN; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; EXTRACELLULAR SPACE; HUMAN; IMMUNOLOGY; KIDNEY DISEASES; METABOLISM; PATHOLOGY; URINE;

MUS;

ADENOSINE TRIPHOSPHATE; ANIMALS; EXTRACELLULAR SPACE; HUMANS; INTERLEUKIN-2; KIDNEY DISEASES; LIPOPOLYSACCHARIDES; MALE; MICE, INBRED C57BL; PROTEINURIA; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTOR 4;

EID: 84908509286     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111285     Document Type: Article

References (47)

1. Chen GY, Nunez G (2010) Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10: 826-837.
2. Couser WG (2012) Basic and translational concepts of immune-mediated glomerular diseases. J Am Soc Nephrol 23: 381-399.
3. Kurts C, Panzer U, Anders HJ, Rees AJ (2013) The immune system and kidney disease: basic concepts and clinical implications. Nat Rev Immunol 13: 738-753.
4. Bertani T, Poggi A, Pozzoni R, Delaini F, Sacchi G, et al. (1982) Adriamycininduced nephrotic syndrome in rats: sequence of pathologic events. Lab Invest 46: 16-23.
5. Bertelli R, Ginevri F, Gusmano R, Ghiggeri GM (1991) Cytotoxic effect of adriamycin and agarose-coupled adriamycin on glomerular epithelial cells: role of free radicals. In Vitro Cell Dev Biol 27A: 799-804.
6. Musante L, Bruschi M, Candiano G, Petretto A, Dimasi N, et al. (2006) Characterization of oxidation end product of plasma albumin in vivo'. Biochem Biophys Res Commun 349: 668-673.
7. Musante L, Candiano G, Petretto A, Bruschi M, Dimasi N, et al. (2007) Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. J Am Soc Nephrol 18: 799-810.
8. Candiano G, Musante L, Bruschi M, Petretto A, Santucci L, et al. (2006) Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. J Am Soc Nephrol 17: 3139-3148.
9. Bertelli R, Bodria M, Nobile M, Alloisio S, Barbieri R, et al. (2011) Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome. Clin Exp Immunol 166: 55-63.
10. Reiser J, von Gersdorff G, Loos M, Oh J, Asanuma K, et al. (2004) Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 113: 1390-1397.
11. Yu CC, Fornoni A, Weins A, Hakroush S, Maiguel D, et al. (2013) Abatacept in b7-1-positive proteinuric kidney disease. N Engl J Med 369: 2416-2423.
12. Alachkar N, Carter-Monroe N, Reiser J (2014) Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med 370: 1263-1264.
13. Rosin DL, Okusa MD (2011) Dangers within: DAMP responses to damage and cell death in kidney disease. J Am Soc Nephrol 22: 416-425.
14. Huang G, Wang Y, Chi H (2012) Regulation of TH17 cell differentiation by innate immune signals. Cell Mol Immunol 9: 287-295.
15. Mai J, Wang H, Yang XF (2010) Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity. Front Biosci (Landmark Ed) 15: 986-1006.
16. Wilson MS, Pesce JT, Ramalingam TR, Thompson RW, Cheever A, et al. (2008) Suppression of Murine Allergic Airway Disease by IL-2:Anti-IL-2 Monoclonal Antibody-Induced Regulatory T Cells. Journal of Immunology 181: 6942-6954.
17. Takabatake Y, Li XK, Mizui M, Miyasato K, Matsui I, et al. (2011) A superagonistic monoclonal antibody for CD28 ameliorates crescentic glomerulonephritis in wistar-kyoto rats. Mol Med 17: 686-696.
18. Le Berre L, Bruneau S, Naulet J, Renaudin K, Buzelin F, et al. (2009) Induction of T regulatory cells attenuates idiopathic nephrotic syndrome. J Am Soc Nephrol 20: 57-67.
19. Wang YM, Zhang GY, Wang Y, Hu M, Wu H, et al. (2006) Foxp3-transduced polyclonal regulatory T cells protect against chronic renal injury from adriamycin. J Am Soc Nephrol 17: 697-706.
20. Saadoun D, Rosenzwajg M, Joly F, Six A, Carrat F, et al. (2011) Regulatory Tcell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med 365: 2067-2077.
21. Boyman O, Kovar M, Rubinstein MP, Surh CD, Sprent J (2006) Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311: 1924-1927.
22. Ferrari D, Pizzirani C, Adinolfi E, Lemoli RM, Curti A, et al. (2006) The P2×7 receptor: a key player in IL-1 processing and release. J Immunol 176: 3877-3883.
23. Webster KE, Walters S, Kohler RE, Mrkvan T, Boyman O, et al. (2009) In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J Exp Med 206: 751-760.
24. Zhao J, Wang H, Dai C, Zhang H, Huang Y, et al. (2013) P2×7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/ caspase 1 pathway. Arthritis Rheum 65: 3176-3185.
25. Schenk U, Frascoli M, Proietti M, Geffers R, Traggiai E, et al. (2011) ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. Sci Signal 4: ra12.
26. Wei C, El Hindi S, Li J, Fornoni A, Goes N, et al. (2011) Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17: 952-960.
27. Wei C, Moller CC, Altintas MM, Li J, Schwarz K, et al. (2008) Modification of kidney barrier function by the urokinase receptor. Nat Med 14: 55-63.
28. Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21: 335-376.
29. Beutler B, Rietschel ET (2003) Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 3: 169-176.
30. Wei C, Trachtman H, Li J, Dong C, Friedman AL, et al. (2013) Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol 23: 2051-2059.
31. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, et al. (2000) Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 24: 251-256.
32. Ghiggeri GM, Caridi G, Magrini U, Sessa A, Savoia A, et al. (2003) Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome). Am J Kidney Dis 41: 95-104.
33. Sanna-Cherchi S, Burgess KE, Nees SN, Caridi G, Weng PL, et al. (2011) Exome sequencing identified MYO1E and NEIL1 as candidate genes for human autosomal recessive steroid-resistant nephrotic syndrome. Kidney Int 80: 389-396.
34. Caridi G, Lugani F, Dagnino M, Gigante M, Iolascon A, et al. (2014) Novel INF2 mutations in an Italian cohort of patients with focal segmental glomerulosclerosis, renal failure and Charcot-Marie-Tooth neuropathy. Nephrol Dial Transplant 29 Suppl 4: iv80-iv86.
35. Vincenti F, Ghiggeri GM (2005) New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis. Am J Transplant 5: 1179-1185.
36. Ohkura N, Hamaguchi M, Sakaguchi S (2011) FOXP3(+) regulatory T cells: control of FOXP3 expression by pharmacological agents. Trends in Pharmacological Sciences 32: 158-166.
37. Kim MG, Koo TY, Yan JJ, Lee E, Han KH, et al. (2013) IL-2/Anti-IL-2 Complex Attenuates Renal Ischemia-Reperfusion Injury through Expansion of Regulatory T Cells. Journal of the American Society of Nephrology 24: 1529-1536.
38. Frascoli M, Marcandalli J, Schenk U, Grassi F (2012) Purinergic P2×7 receptor drives T cell lineage choice and shapes peripheral gammadelta cells. J Immunol 189: 174-180.
39. Solini A, Menini S, Rossi C, Ricci C, Santini E, et al. (2013) The purinergic 2×7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation. J Pathol 231: 342-353.
40. Geertsen PF, von der Maase H, Olsen NV, Fogh-Andersen N, Nielsen SL, et al. (1998) Renal haemodynamics, sodium and water reabsorption during continuous intravenous infusion of recombinant interleukin-2. Clin Sci (Lond) 95: 73-81.
41. Brenner BM, Hostetter TH, Humes HD (1978) Molecular basis of proteinuria of glomerular origin. N Engl J Med 298: 826-833.
42. Brenner BM, Humes HD (1977) Mechanics of glomerular ultrafiltration. N Engl J Med 297: 148-154.
43. Polhill T, Zhang GY, Hu M, Sawyer A, Zhou JJ, et al. (2012) IL-2/IL-2Ab complexes induce regulatory T cell expansion and protect against proteinuric CKD. J Am Soc Nephrol 23: 1303-1308.
44. Shevach EM (2012) Application of IL-2 therapy to target T regulatory cell function. Trends Immunol 33: 626-632.
45. Shalhoub RJ (1974) Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2: 556-560.
46. Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M (1991) A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 40: 453-460.
47. Araya C, Diaz L, Wasserfall C, Atkinson M, Mu W, et al. (2009) T regulatory cell function in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 24: 1691-1698.